AELMHU has opened the application period for the eighth edition of its awards, which aim to promote awareness and visibility of rare diseases and orphan drugs.

Since their first edition in 2017, the AELMHU Awards have established themselves as the benchmark awards in the field of rare diseases, recognizing the work of professionals, patient associations, healthcare organizations, and researchers who contribute to improving the approach, awareness, and scientific knowledge of these pathologies.